Post by Regeneron
667,589 followers
Following the science is not a slogan for us; it’s a discipline. It guides how we invest in, develop and deliver breakthrough medicines. Building on continued progress across our science and technologies, we’re strengthening our pipeline and portfolio across multiple therapeutic areas, including cancer, rare diseases, immunology and more. As we look ahead, we remain grounded in our commitment to doing good while working to change what's possible in medicine. To everyone at Regeneron helping to drive this momentum forward, thank you. We are inspired by the impact our medicines have on patients’ lives and energized by the therapies we have yet to discover. See how we’re shaping what’s next: https://bit.ly/4ueXKq9
Video Content